UPDATE: Dyax Corp. (DYAX) Slammed; to Discontinue Ecallantide Phase 2 Based on Results of Interim Analysis
Tweet Send to a Friend
(Updated - June 14, 2012 4:10 PM EDT)
UPDATE - Shares are down 13 percent in after-hours trading
This article: 347 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UPDATE - Shares are down 13 percent in after-hours trading
This article: 347 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
